Antimicrobial Susceptibility Testing Market (Type - Antimicrobial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, and Other Susceptibility Testing; Technology - Disk Diffusion Method, Broth Microdilution, and Automated Instrument; Application - Clinical Diagnostics, Drug Discovery and Development, Epidemiology, and Other Applications; End User - Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, and Clinical Research Organizations): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

A recent report published by Infinium Global Research on antimicrobial susceptibility testing market provides in-depth analysis of segments and sub-segments in the global as well as regional antimicrobial susceptibility testing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional antimicrobial susceptibility testing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global antimicrobial susceptibility testing market.

Market Insight:

The global antimicrobial susceptibility testing market was valued at USD 3,545.8 million in 2022 and is expected to reach USD 5,986.31 million in 2030, with a CAGR of 5.95% during the forecast period 2023-2030.

Antimicrobial susceptibility testing is a biotechnological and pharmaceutical laboratory technique that is used to detect and identify antimicrobial activity and its susceptibility per individual. The process of susceptibility occurs when microns such as bacteria or fungi are indisposed to survive in the presence of some specific antimicrobial drugs. It is also best suitable to choose between a variety of antibiotics and their action mechanisms. In a wider scenario, antimicrobial susceptibility testing aids the examination and evaluation of treatments of various pathological diseases by healthcare facility centers such as hospitals, clinics, government facility centers to offer surveillance and minimize and the widespread of infectious diseases. AST or antimicrobial susceptibility testing is highly prevailed by pharmaceutical organizations to potentially govern the efficacy of antimicrobial drugs on the resistant bacterial and viral species for manufacturing counteracting drugs. AST procedures are undoubtedly considered the most accurate and efficient methods to detect the activity of the principal compound on fungal, viral, and bacterial culture at clinical as well as research levels, which has significantly expanded its use and has proportionally cherished the market growth.

A rigorous increase in chronic diseases caused due to evolution of antibody resistance microbes has prevailed in the use of antimicrobial susceptibility testing. Diseases caused by microbes such as Neisseria meningitidis and gonorrhea, Salmonella typhi, and Shigella due to lack of sanitation, unhealthy water, and unhygienic living conditions are typically boosting the demand for antimicrobial susceptibility testing in developing countries. The necessity to create counteracting drugs against these microbes has incrementally uplifted the use of these testing kits at the clinical microbiology level. A further growing number of hospital-acquired infections and a continuous rise in the number of patients across the globe, specifically in the developing economies, along with rising government initiatives to prevent the disease spread is propelling the AST market. However, a lack of awareness about the importance of antimicrobial susceptibility testing and its role in guiding appropriate antibiotic therapy is restraining the market. Moreover, over the forecast period, increasing demand for point-of-care testing and high-tech automated testing done by using AST cards and panels is expected to create lucrative growth opportunities for market growth.

The global antimicrobial susceptibility testing market is segmented into the Asia Pacific, North America, Europe, the Middle East & Africa, and South America. Among the regions, North America is anticipated to dominate the antimicrobial susceptibility testing market over the forecast period owing to the presence of key industry leaders in the region. Moreover, investment in technological advancements by the regional manufacturers to offer cutting-edge products is another key factor fueling the market growth. Asia Pacific is projected to witness lucrative growth opportunities over the forecast years due to continuous growth in the regional population. Since the Asia Pacific accommodates multiple under-developing regions with growing investments healthcare industry, the market for antimicrobial susceptibility testing will garner applauding growth in the region by the year 2030.

Report Scope of the Antimicrobial Susceptibility Testing Market:

Segment Covered

The report on global antimicrobial susceptibility testing market covers segments such as type, technology, application, and end user. On the basis of type, the sub-markets include antimicrobial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and other susceptibility testing. On the basis of technology, the sub-markets include disk diffusion method, broth microdilution, and automated instrument. On the basis of application, the sub-markets include clinical diagnostics, drug discovery and development, epidemiology, and other applications. On the basis of end user, the sub-markets include hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research and academic institutes, and clinical research organizations.

Companies Profiled:

The report provides profiles of the companies in the market such as Accelerate Diagnostics, Inc., BD, BIOMÉRIEUX, Bruker, Bio-Rad Laboratories, Inc., Creative Diagnostics, HiMedia Laboratories, Alifax S.r.l., Thermo Fisher Scientific Inc., and Mast Group Ltd..

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the antimicrobial susceptibility testing market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.